You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. BIODESIX INC

Biodesix Inc XNAS: BDSX

Biodesix Inc Live Share Price Today, Share Analysis and Chart

Weak Stock
Download real time

0.55 0.00 (0.00%)

73.04% Fall from 52W High

348.6K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Biodesix Inc Key Metrics

Default

Market Capitalization

Below industry Median
80.3

PE TTM

Negative PE TTM
-1.9

PEG TTM

Negative PEG TTM
-0.1

Price to Book

Below industry Median
3.8

Institutional holding current Qtr %

Below industry Median
40.5

Revenue Growth Qtr YoY %

High in industry
39.3

Operating Revenue growth TTM %

High in industry
45.3

Net Profit Qtr Growth YoY %

Below industry Median
9.7

Net Profit TTM Growth %

Below industry Median
17.7

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-32

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-48

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-44.2

ROE Annual %

Negative ROE Annual %
-337.3

RoA Annual %

Negative RoA Annual %
-43.7
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
11.3 / 100
Momentum Score
Technically Bearish
26.4 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
3
1Yr Price target upside is 464%
5 analysts

11

S

16

W

1

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Biodesix Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26050100150Actual RevenueAvg. Estimate
Miss

Biodesix Inc's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

Current EPS
-0.3
Avg. Estimate
-0.2
Low Estimate
-0.2
High Estimate
-0.2
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 36.4% in FY25

Consensus Recommendation

6 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Buy5Strong Buy

The consensus recommendation from 6 analysts for Biodesix Inc is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Biodesix Inc Stock Analysis

Biodesix Inc stock analysis with key metrics, changes, and trends.

Biodesix Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$71.32 M45.3%positive

Annual Revenue rose 45.3%, in the last year to $71.32 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

Annual Net Profit$42.93 M17.67%positive

Annual Net Profit rose 17.67% in the last year to $42.93 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio-1.87-negative

Price to Earning Ratio is -1.87, which is negative.

Stock Price$0.55-56%negative

Stock Price fell 56% and underperformed its sector by 60.18% in the past year.

Quarterly Revenue$20.43 M39.28%positive

Quarterly Revenue rose 39.28% YoY to $20.43 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

Quarterly Net profit$8.25 M9.72%positive

Quarterly Net profit rose 9.72% YoY to $8.25 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

Debt to Equity Ratio2.97-negative

Debt to Equity Ratio of 2.97 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-337.30 %-337.3%negative

Return on Equity(ROE) for the last financial year was -337.3%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding5.42 %0%negative

Mutual Fund Holding decreased by 0% in the last quarter to 5.42.

Interest Coverage Ratio-4.2-negative

Interest Coverage Ratio is -4.2, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding40.48 %0%neutral

Institutional Holding remained the same in the last quarter at 40.48%.

VIEW LESS


Loading data..

Biodesix Inc - Company Profile

What does Biodesix Inc do?

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Biodesix Inc Management structure

All Gross Remunerations are in USD
Mr. Scott Hutton
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Ms. Robin Harper Cowie
Chief Financial Officer, Secretary and Treasurer
-
2024
Gross Remuneration
Year
Mr. Christopher Vazquez
Vice President, Chief Accounting Officer and Controller
-
2024
Gross Remuneration
Year

Biodesix Inc Board of directors

All Gross Remunerations are in USD
Mr. Jack W. Schuler
Independent Director
-
2025
Gross Remuneration
Year
Dr. Charles Watts, M.D.
Independent Director
-
2025
Gross Remuneration
Year

Biodesix Inc FAQ

How is Biodesix Inc today?
Biodesix Inc today is trading in the red, and is down by 0.00% at 0.55.
Biodesix Inc is currently trading down 0.00% on an intraday basis. In the past week the stock rose 3.77%. stock has been down -52.17% in the past quarter and fell -56.00% in the past year. You can view this in the overview section.